Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma 9Breast Neoplasms 9Squamous Cell Carcinoma of Head and Neck 6Head and Neck Neoplasms 6Lymphoma, Follicular 5Neuroblastoma 4Central Nervous System Neoplasms 4Sarcoma 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Brain Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Salivary Gland Neoplasms 2Lymphoma, Large-Cell, Immunoblastic 2Lung Neoplasms 2Kidney Neoplasms 2Hodgkin Disease 2Gliosarcoma 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms, Male 2Wilms Tumor 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Teratoma 1Sarcoma, Kaposi 1Rhabdoid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1

Interventions

Cyclophosphamide 5Epirubicin 4Docetaxel 4pegfilgrastim 2Trastuzumab 2Radiotherapy 2Filgrastim 2Doxorubicin 2Bevacizumab 2Taxes 1Surgical Procedures, Operative 1Paclitaxel 1Neoadjuvant Therapy 1Microarray Analysis 1Lapatinib 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Inflammatory Breast Neoplasms × Immunohistochemistry × Clear all
NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
1,856 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡